Influenza hemagglutinin (HA) peptide
≥97% (HPLC)
- Product Code: 110788
CAS:
92000-76-5
| Molecular Weight: | 1102.15 g./mol | Molecular Formula: | C₅₃H₆₇N₉O₁₇ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD01310914 | |
| Melting Point: | Boiling Point: | ||
| Density: | 1.414±0.06 g/cm3 (20 ºC 760 Torr) | Storage Condition: | -20°C |
Product Description:
Influenza hemagglutinin (HA) peptide is widely used in immunology and vaccine development. It serves as a key component in the design of influenza vaccines, helping to elicit an immune response against the virus. Researchers utilize HA peptides to study antibody binding and immune system recognition, which is critical for understanding viral infection mechanisms. Additionally, these peptides are employed in diagnostic assays to detect influenza-specific antibodies in patient samples. HA peptides also play a role in the development of universal flu vaccines, aiming to provide broader protection against various influenza strains. Their application extends to preclinical studies, where they are used to evaluate the efficacy of new antiviral therapies and vaccine candidates.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Or Off-White Lyophilized Powder |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿4,110.00 |
+
-
|
| 0.002 | 10-20 days | ฿5,870.00 |
+
-
|
| 0.005 | 10-20 days | ฿11,300.00 |
+
-
|
Influenza hemagglutinin (HA) peptide
Influenza hemagglutinin (HA) peptide is widely used in immunology and vaccine development. It serves as a key component in the design of influenza vaccines, helping to elicit an immune response against the virus. Researchers utilize HA peptides to study antibody binding and immune system recognition, which is critical for understanding viral infection mechanisms. Additionally, these peptides are employed in diagnostic assays to detect influenza-specific antibodies in patient samples. HA peptides also play a role in the development of universal flu vaccines, aiming to provide broader protection against various influenza strains. Their application extends to preclinical studies, where they are used to evaluate the efficacy of new antiviral therapies and vaccine candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :